Trials / Completed
CompletedNCT00390390
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial of 14 Day Treatment With Lansoprazole 15 mg Once a Day in Frequent Heartburn
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 576 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Heartburn, a burning sensation in the chest or throat, occurs in many patients when acidic stomach contents move into the esophagus from the stomach. This study will investigate the safety and efficacy of lansoprazole 15 mg once a day in treating frequent heartburn.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lansoprazole |
Timeline
- Start date
- 2006-06-01
- Completion
- 2007-01-01
- First posted
- 2006-10-19
- Last updated
- 2010-05-25
Locations
30 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00390390. Inclusion in this directory is not an endorsement.